source
- STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and moreSanofi is experiencing shortages of two medicines used to treat Pompe disease after the FDA warned the company over manufacturing issuesSTAT · 7h ago↗ source
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualmsThe FDA has denied ITM Isotopes Technologies’ lead pipeline candidate for a rare group of tumors due to qualms over the drug’s manufacturing.Fierce Biotech · 10h ago↗ source
- Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drugScholar Rock has dropped Novo Nordisk’s troubled Catalent facility as a contract manufacturer in its FDA refiling for apitegromab, a spinal muscular atrophy candidate, after a recent inspection of…